NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $33.49 -0.27 (-0.80%) As of 10:58 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get REVS alerts:Sign Up Key Stats Today's Range$33.52▼$33.6050-Day Range$32.80▼$34.3752-Week Range$27.24▼$34.55Volume3,871 shsAverage Volume50,407 shsMarket Capitalization$368.39 millionAssets Under Management$373.70 millionDividend YieldN/ANet Expense Ratio0.19%Aggregate RatingModerate Buy ETF Overview The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia. Read More Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.57%0.50%0.53%Other Expenses0.01%0.28%0.53%0.60%0.54%Total Expense0.20%0.64%0.75%0.75%0.73%Fee Waiver-0.01%-0.27%-0.67%-0.78%-0.68%Net Expense0.19%0.61%0.63%0.57%0.60% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. REVS ETF News Headlines(REVS) Columbia Research Enhanced Value ETFAugust 30, 2026 | sa.investing.comColumbia Research Enhanced International Equity ETFJune 10, 2026 | barrons.comThe Midwestern Disruptor Big Pharma Doesn’t Want You to Know AboutA little-known Midwestern firm sits at the center of what the Wall Street Journal calls medicine's biggest moment since antibiotics. It does not invent drugs or hold blockbuster patents. McKinsey calls the shift a game changer, and the International Journal of Surgery describes it as a revolutionary path forward. Yet this company remains largely overlooked by investors. See the full research on this emerging healthcare story now.October 14 at 1:00 AM | Compounding Quality (Ad)Columbia Research Enhanced Real Estate ETF declares quarterly distribution of $0.6354December 19, 2025 | msn.comFidelity Enhanced Large Cap Value ETF declares quarterly distribution of $0.1460September 29, 2025 | msn.comColumbia Research Enhanced Core ETF (ARCA:RECS), Top HoldingsJuly 8, 2025 | benzinga.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $28.28 on January 1st, 2026. Since then, REVS shares have increased by 19.4% and is now trading at $33.76. Who are Columbia Research Enhanced Value ETF's major shareholders? Columbia Research Enhanced Value ETF's top institutional shareholders include Farther Finance Advisors LLC (0.01%) and CoreCap Advisors LLC (0.01%). How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang, Henry Hom WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings610 Fund Statistics Assets Under Management$373.70 million Average Daily Volume$0.00 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorColumbia Management Investment Advisers, LLC CustodianState Street Bank and Trust Company DistributorALPS Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest50,920 shs Miscellaneous Outstanding Shares11,000,000Beta0.79 Creation Unit25,000 Creation Fee$500.00 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 REVS HoldingsApple (NASDAQ:AAPL)Holding Weight: 8.75%Microsoft (NASDAQ:MSFT)Holding Weight: 7.82%Bank of America (NYSE:BAC)Holding Weight: 3.35%Chevron (NYSE:CVX)Holding Weight: 2.90%Meta Platforms (NASDAQ:META)Holding Weight: 2.42%Altria Group (NYSE:MO)Holding Weight: 2.24%Citigroup (NYSE:C)Holding Weight: 1.84%Cisco Systems (NASDAQ:CSCO)Holding Weight: 1.68%Bristol Myers Squibb (NYSE:BMY)Holding Weight: 1.63%Charles Schwab (NYSE:SCHW)Holding Weight: 1.54%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredForget Biotech Stocks… This Is the Smarter PlayNVIDIA, Shopify, and TSMC built fortunes by powering innovation rather than betting on a single winner. One li...Compounding Quality | SponsoredThe most boring strategy I knowCovered calls won't make you rich overnight, and they cap your upside if a stock takes off. But many retired i...Profits Run | SponsoredYou waited. Micron didn't.On October 15, 2025, Seeking Alpha's Quant system added Micron Technology (MU) to its Alpha Picks portfolio. I...Seeking Alpha | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
